Barinthus Biotherapeutics (BRNS) Interest Coverage Ratio (2020 - 2026)
Barinthus Biotherapeutics (BRNS) reported Interest Coverage Ratio of 467.31 for Q1 2026, up 70.51% on a YoY basis from 274.07 in Q1 2025, and up 47.47% quarter-over-quarter from 889.62 in Q4 2025.
Barinthus Biotherapeutics (BRNS) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
Barinthus Biotherapeutics has reported Interest Coverage Ratio for 7 years, with the latest figure at 467.31 in Q1 2026.
- For the quarter ending Q1 2026, Interest Coverage Ratio rose 70.51% year-over-year to 467.31; the trailing twelve-month figure through Mar 2026 stood at 1098.63 (up 17.21% YoY), and the FY2025 full-year result was 1383.43, down 7.87% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 467.31, up from 889.62 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 8.84 in Q1 2022, with the low at 2855.43 in Q4 2023.
- Historically, Interest Coverage Ratio has averaged 1423.61 across 5 years, with a median of 1523.83 in 2024.
- Annual changes were most pronounced in 2022 — Interest Coverage Ratio jumped 479.46% — and 2025, when it plunged 110.04%.
- Barinthus Biotherapeutics' Interest Coverage Ratio stood at 8.84 in 2022, then sank by 32409.13% to 2855.43 in 2023, then surged by 31.74% to 1949.17 in 2024, then jumped by 54.36% to 889.62 in 2025, then soared by 47.47% to 467.31 in 2026.
- The last three Interest Coverage Ratio figures came in at 467.31 (Q1 2026), 889.62 (Q4 2025), and 1158.92 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -258.33 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 11.79 |
| 10 | Barinthus Biotherapeutics | 27.08 Mn | -40.03 Mn | - | -467.31 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -467.31 |
| Dec 31, 2025 | -889.62 |
| Sep 30, 2025 | -1,158.92 |
| Jun 30, 2025 | -1,943.67 |
| Mar 31, 2025 | -1,584.62 |
| Dec 31, 2024 | -1,949.17 |
| Sep 30, 2024 | -551.76 |
| Jun 30, 2024 | -1,523.83 |
| Mar 31, 2024 | -1,409.50 |
| Dec 31, 2023 | -2,855.43 |
| Sep 30, 2023 | -2,300.71 |
| Jun 30, 2023 | -1,881.21 |
| Mar 31, 2022 | 8.84 |
| Dec 31, 2021 | -926.00 |
| Mar 31, 2021 | -2.33 |
| Dec 31, 2020 | -3.66 |
| Sep 30, 2020 | -1.47 |